Almac building facility in Ireland

Almac Group is building a new facility in Ireland as part of its ongoing expansions.

Just weeks after announcing plans to expand and add jobs in the U.S., CDMO Almac is doing the same in Ireland. Almac will build a new facility in Dundalk, County Louth, near the border with its home country of Northern Ireland.

Almac announced today that it will make a multimillion-euro investment at an Ireland Development Authority business park. It is getting some support for Ireland’s Department of Jobs. The  company offered few details but said the new 32,000-square-foot facility will be used by its pharma and clinical services units.

Almac, which has been steadily expanding for several years, laid out a multiproject blueprint in November to make small investments in a number of its facilities, as well as a significant expansion to its U.S. headquarters.

Conference

The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

The company is spending $25 million (£20 million) to expand its 240,000-square-foot offices at its U.S. headquarters in Souderton, Pennsylvania, and to lease a 26,000-square-foot office space in nearby Lansdale. The drug services company is getting about $1.6 million in state support for the project and has committed to adding 312 jobs.

At the time, it also said it would invest about $2.5 million (£2 million) to upgrade facilities at the Arran Chemical Company facility in Athlone, Ireland that it bought last year. Almac is investing another $6.3 million (£5 million) to build an additional laboratory and office facility at its global headquarters in Craigavon, Northern Ireland. The company said about 170 existing employees will move to the new facility.

Suggested Articles

The FDA lambasted Strides Pharma in a warning letter after inspectors found testing records in the trash and in bags by a shredder.

Chinese biotech CMBG hopes to get a cell manufacturing facility built in nine months and more manufacturing news of note.

Kite has been buying the viral vector starting material for its CAR-T treatment Yescarta from contractors but says it is time to produce its own.